As of Mar 29
| 0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for BioDelivery Sciences International Inc have a median target of 4.50, with a high estimate of 8.00 and a low estimate of 3.00. The median estimate represents a +136.84% increase from the last price of 1.90.
The current consensus among 6 polled investment analysts is to Buy stock in BioDelivery Sciences International Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.